| Product Code: ETC6903507 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of rapid-acting insulin to Cyprus have shown significant growth, with a high Herfindahl-Hirschman Index (HHI) indicating a very high concentration of imports in 2024. Top exporting countries include Metropolitan France, Belgium, Denmark, UK, and USA. The compound annual growth rate (CAGR) from 2020 to 2024 is an impressive 110.54%, with a notable growth rate of 52.24% in 2024 alone. This data suggests a strong demand for rapid-acting insulin in Cyprus, with key suppliers capturing a larger share of the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Rapid Acting Insulin Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Rapid Acting Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Rapid Acting Insulin Market - Industry Life Cycle |
3.4 Cyprus Rapid Acting Insulin Market - Porter's Five Forces |
3.5 Cyprus Rapid Acting Insulin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Cyprus Rapid Acting Insulin Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Cyprus Rapid Acting Insulin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Cyprus Rapid Acting Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Rapid Acting Insulin Market Trends |
6 Cyprus Rapid Acting Insulin Market, By Types |
6.1 Cyprus Rapid Acting Insulin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Rapid Acting Insulin Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Cyprus Rapid Acting Insulin Market Revenues & Volume, By Lispro Insulin, 2021- 2031F |
6.1.4 Cyprus Rapid Acting Insulin Market Revenues & Volume, By Aspart Insulin, 2021- 2031F |
6.1.5 Cyprus Rapid Acting Insulin Market Revenues & Volume, By Glulisine Insulin, 2021- 2031F |
6.2 Cyprus Rapid Acting Insulin Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Rapid Acting Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021- 2031F |
6.2.3 Cyprus Rapid Acting Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F |
6.3 Cyprus Rapid Acting Insulin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Rapid Acting Insulin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Cyprus Rapid Acting Insulin Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.3.4 Cyprus Rapid Acting Insulin Market Revenues & Volume, By Online Stores, 2021- 2031F |
7 Cyprus Rapid Acting Insulin Market Import-Export Trade Statistics |
7.1 Cyprus Rapid Acting Insulin Market Export to Major Countries |
7.2 Cyprus Rapid Acting Insulin Market Imports from Major Countries |
8 Cyprus Rapid Acting Insulin Market Key Performance Indicators |
9 Cyprus Rapid Acting Insulin Market - Opportunity Assessment |
9.1 Cyprus Rapid Acting Insulin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Cyprus Rapid Acting Insulin Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Cyprus Rapid Acting Insulin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Cyprus Rapid Acting Insulin Market - Competitive Landscape |
10.1 Cyprus Rapid Acting Insulin Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Rapid Acting Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |